In breast cancer, POH1 protein expression assessed by immunohistochemistry was found to be higher in tumour tissue than in adjacent normal tissue and to correlate by retrospective analysis with worse prognosis in terms of overall survival both in the population of 142 cases and in a validation reference population. Here, PSMD14 is linked to breast cancer.